Yanwan Shangguan
Overview
Explore the profile of Yanwan Shangguan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu W, Li X, Guo W, Shangguan Y, Xia J, Feng X, et al.
J Mol Diagn
. 2024 Jul;
26(9):832-842.
PMID: 38972592
Timely detection of Aspergillus infection is crucial given the high mortality rate of pulmonary aspergillosis (PA). Here, the diagnostic performances for PA of mycological culture, Aspergillus real-time PCR, and metagenomic...
2.
Guo W, Li X, Ding C, Dai X, Wu S, Shi Y, et al.
BMC Pulm Med
. 2024 Jul;
24(1):312.
PMID: 38961438
Background: The Omicron variant broke out in China at the end of 2022, causing a considerable number of severe cases and even deaths. The study aimed to identify risk factors...
3.
Guo W, Shangguan Y, Ji Z, Hu M, Li X, Hu W, et al.
J Glob Antimicrob Resist
. 2024 May;
38:83-89.
PMID: 38719186
Objectives: Mycobacterium abscessus complex (MABC) is the most common rapidly growing Mycobacterium species in structural pulmonary diseases and can be life-threatening. This study aimed to assess the clinical characteristics and...
4.
Guo W, Hu M, Xu N, Shangguan Y, Xia J, Hu W, et al.
Int J Antimicrob Agents
. 2023 Jun;
62(2):106875.
PMID: 37276894
Central nervous system (CNS) tuberculosis (TB) is a devastating and often life-threatening disease caused by Mycobacterium tuberculosis. Contezolid, a new oxazolidinone, has demonstrated potent antimycobacterial activity in both in-vivo and...
5.
Shangguan Y, Guo W, Feng X, Shi Y, Li X, Pan Z, et al.
Int J Infect Dis
. 2023 Apr;
132:99-107.
PMID: 37068583
Objectives: Faropenem has antituberculosis activity in vitro but its utility in treating patients with tuberculosis (TB) is unclear. Methods: We conducted an open-label, randomized trial in China, involving newly diagnosed,...
6.
Shangguan Y, Ji Z, Guo W, Hu W, Li X, Xu K
Infect Drug Resist
. 2022 Sep;
15:5449-5454.
PMID: 36128436
Linezolid-induced black hairy tongue is a self-limiting benign disease that is rare. Here, we report three patients who developed black hairy tongue after linezolid treatment. The severe dysbiosis of oral...
7.
Shi Y, Guo W, Hu W, Li X, Shangguan Y, Feng X, et al.
Infect Drug Resist
. 2022 May;
15:2633-2638.
PMID: 35634580
Tuberculous aortitis (TA) is a rare disease with a high mortality rate. Aortic pseudoaneurysm is the most common vascular pattern of TA, and isolated arterial wall thickening and arterial stenosis...
8.
Ding C, Hu M, Guo W, Hu W, Li X, Wang S, et al.
Int J Infect Dis
. 2022 May;
122:46-62.
PMID: 35577247
Objectives: To track the prevalence trends of latent tuberculosis infection (LTBI) at the global, regional, and national levels. Methods: Data on the prevalence of LTBI were extracted from the Global...
9.
Ding C, Hu M, Shangguan Y, Guo W, Wang S, Feng X, et al.
Front Med (Lausanne)
. 2022 Mar;
9:798465.
PMID: 35308541
Objective: To estimate the epidemic trends of tuberculosis (TB) in 30 high burden countries (HBCs) over the past 30 years, which is crucial for tracking the status of disease control,...
10.
Guo W, Feng X, Hu M, Shangguan Y, Xia J, Hu W, et al.
Front Cell Infect Microbiol
. 2022 Jan;
11:783568.
PMID: 35096640
Background: Fever of unknown origin (FUO) is still a challenge for clinicians. Next-generation sequencing technologies, such as whole exome sequencing (WES), can be used to identify genetic defects in patients...